Skip to main content
logo
BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
4.770
-0.120 (-2.45%)
At close: Sep 18, 2026, 4:00 PM EDT
4.834
+0.064 (1.34%)
After-hours: Sep 18, 2026, 7:30 PM EDT

BBOT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Market Capitalization
3821,001247-
Market Cap Growth
-55.25%305.70%--
Enterprise Value
41536--
Last Close Price
4.7712.5210.50-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PB Ratio
1.182.441.71-
P/TBV Ratio
1.182.44--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.010.01--
Net Debt / Equity Ratio
-1.06-1.03-1.070.02
Net Debt / EBITDA Ratio
1.722.901.930.00
Net Debt / FCF Ratio
2.253.692.830.01
Quick Ratio
4.3812.157.950.12
Current Ratio
4.6912.348.110.24
Return on Equity (ROE)
-81.92%-48.23%-110.95%-
Return on Assets (ROA)
-47.11%-29.75%-59.37%-
Return on Capital Employed (ROCE)
-61.20%-35.30%-55.90%597.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-47.62%-13.38%-30.09%-
FCF Yield
-39.63%-11.43%-22.31%-
Buyback Yield / Dilution
-12503.20%-241276.23%89.66%-